![Mohammad Hirmand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohammad Hirmand
Directeur/Bestuurslid bij
WHITEHAWK THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2026
Profiel
Dr. Mohammad Hirmand, MD, is Chief Medical Officer & Executive Vice President bij Turning Point Therapeutics, Inc. Dr. Hirmand was voorheen werkzaam als Vice President-Clinical Development bij Medivation LLC (California), Associate Director-Clinical Research bij Amgen, Inc., Senior Director-Clinical Development bij ARCA biopharma, Inc., Manager-Market Development & Product Evaluation bij Innoviva, Inc, senior Director-Clinical Development bij Nuvelo, Inc., Chief Medical Officer bij Peloton Therapeutics, Inc., Director-Oncology Development bij SuperGen, Inc., Principal bij Theravance Biopharma US, Inc., en Manager-Clinical Data bij Tularik, Inc. Hij behaalde zijn doctoraatsdiploma aan de Cornell University en een doctoraatsdiploma aan de Harvard Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Mohammad Hirmand
| Bedrijven | Functie | Begin |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Directeur/Bestuurslid | 27-03-2023 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Oprichter | 01-08-2022 |
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mohammad Hirmand
| Bedrijven | Functie | Einde |
|---|---|---|
| TURG POIN | Hoofd Techniek/Wetenschap/O&O | 01-08-2022 |
| PELOTON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 31-12-2019 |
| MEDIVATION INC | Operationeel Directeur | 01-10-2015 |
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Corporate Officer/Principal | - |
| ARCA BIOPHARMA | Corporate Officer/Principal | - |
Opleiding van Mohammad Hirmand
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
39
Eerstegraads connecties
15
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 15 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
Kies MarketScreener 
